Science & Enterprise subscription

Follow us on Twitter

  • I just published Get Ready for Biological Programming, on Medium https://t.co/DGTKC7c4t0 Writing code with cells and genes.
    about 20 hours ago
  • The Pew Research Center last month reported results of surveys about mobile phone use, conducted in 11 emerging eco… https://t.co/EEmV2FmKas
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Mobile Phones in Emerging Economies https://t.co/MXoyQkhwIu #Science #Business
    about 2 days ago
  • Thank you @SciSeeker ... that's very kind. Where can I find a Science Seeker logo I can put on our site, to indicat… https://t.co/kXVMa32BHZ
    about 3 days ago
  • A biomedical engineering team devised techniques using a gel to produce more engineered T-cells, which in lab mice… https://t.co/d9GwEsAjxo
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

In Case You Missed It …

(tigerlily713, Pixabay)

19 August 2018. As our infographic yesterday indicates, the opioid crisis shows few signs of abating anytime soon. And while much of the current surge in overdose deaths is from synthetic opioid drugs like fentanyl, the roots of the crisis can be traced to abuse of prescription pain drugs.

As a result, new ways of treating acute and chronic pain are badly needed. A story last week in Science & Enterprise reports on a new NIH grant to the company Peptide Logic in San Diego, developing synthetic peptides, short chains of amino acids similar to proteins. The peptides in this case act on kappa opioid receptors, pain receptors in tissue and muscles outside the central nervous system, which unlike today’s opioid pain drugs that can be addictive, do not affect the brain. The 2-year award of nearly $3 million aims to advance the technology to the point of clinical trials.

Here are other stories we covered last week:

*     *     *

Please share Science & Enterprise ...

Comments are closed.